Cephalalgia

Primary headaches are classified as migraine, tension-type, or cluster and other trigeminal autonomic cephalalgias. [Pg.501]

Cluster Headache and Other Trigeminal Autonomic Cephalalgias... [Pg.502]

Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004 24(Suppl 1 ) 1—160. [Pg.511]

I Ciancarelli, M Tozzi-Ciancarelli, C Di Massimo, C Marini, A Carolei. Cephalalgia 23 39-42, 2003. [Pg.959]

Couturier EG, Hering R, Steiner TJ. (1992). Weekend attacks in migraine patients caused by caffeine withdrawal Cephalalgia. 12(2) 99-100. [Pg.521]

Vogler BK, Pittler MH, Ernst E. (1998). Feverfew as a preventive treatment for migraine a systematic review. Cephalalgia. 18(10) 704-8. [Pg.533]

Headache To abort or prevent vascular headaches such as migraine, migraine variant, and cluster headache (histaminic cephalalgia). [Pg.968]

Wilkinson M, Pfaffenrath V, Schoenen J, Diener HC, Steiner TJ. Migraine and cluster headache their management with sumatriptan a critical review of the current clinical experience. Cephalalgia 1995 15 337-57. [Pg.706]

D Andrea, G., Granella, F., Cadaldini, M., Manzoni, G. C. Effectiveness of lamotrigine in the prophylaxis of migraine with aura an open pilot study, Cephalalgia 1999 19, 64-66. [Pg.324]

Lampl, C., Buzath, A., Klinger, D., Neuman, K.. Lamotrigine in the prophylactic treatment of migraine aura a pilot study, Cephalalgia 1999, 19, 58-63. [Pg.328]

Steiner, T. J., Findley, L. J., Yuen, A. W.. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura, Cephalalgia 1997, 17, 1009-112. [Pg.330]

Connor, H., Bertin, L., Gillies, S., Beattie, D., Ward, P. Clinical evaluation of a novel, potent, CNS penetrating NK1 receptor antagonist in the acute treatment of migraine, Cephalalgia 1998, 18, 392. [Pg.535]

Cutler, N., Gomez-Mancilla, B., Leibowitz, M., Fleishaker, J. A study of safety and efficacy in patients with acute migraine, using PNU-142633, a selective 5-HT1D agonist, Cephalalgia 2000, 20, 268. [Pg.535]

Goldstein, D., Wang, O., Saper, J., Stoltz, R., Silberstein, S., Mathew, N. Ineffectiveness of neurokinin-1 antagonist in acute migraine a crossover study. Cephalalgia 1996, 17, 785-790. [Pg.536]

Edvinsson, L. and Goadsby, P. Neuropeptides in migraine and cluster headache, Cephalalgia 1994, 14, 320-327. [Pg.552]

Ottoson, A. and Edvinsson, L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide, Cephalalgia 1997, 17, 166-74. [Pg.553]

Williamson DJ, Hargreaves RJ, Hill RJ, Shepheard SL (1997) Sumatriptan inhibits neurogenic vasodilation of dural blood vassels in the anaesthetized rat—intravital microscope studies. Cephalalgia 17 525-31... [Pg.574]

Pascual J, del Arco C, Romon T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996 16 317-322. [Pg.355]

Buzzi MG, Moskowitz MA. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 1991 11 165-168. [Pg.401]

Diener HC, Krupp P, Schmitt T, Steitz G, Milde K, Freytag S. Cyclandelate in the prophylaxis of migraine a placebo-controlled study. Cephalalgia 2001 21(l) 66-70. [Pg.1023]

Single cases of benign intracranial hypertension (pseudotumor cerebri), with and without ocular palsy, have been reported (35,36). Uncharacteristic general symptoms, with dizziness, cephalalgia, or drowsiness, are more frequent. [Pg.2543]

Srikiatkhachorn A, Anthony M. Serotouiu receptor adaptation in patients with analgesic-induced headache. Cephalalgia 1996 16(6) 419-22. [Pg.2690]

Rolan P. Potential drug interactions with the novel anti-migraine compound zolmitriptan (Zomig, 311C90). Cephalalgia 1997 17(Suppl 18) 21-7. [Pg.3528]

Pfaffenrath V, Diener HC, Fischeer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxix— a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002 22(7) 523-532. [Pg.121]

Verri, A., R. E. Nappi, E. Vallero, C. Galli, G. Sances and E. Mar-tignoni (1997). Premenstrual dysphoric disorder and eating disorders. Cephalalgia 17(Suppl 20) 25-8. [Pg.92]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...